<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>rgpv syllabus - rgpv timetable Microsoft Word - M Pharm PCI Syllabus all branches</title><meta name="author" content="HP"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 .p, p { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; margin:0pt; }
 .s3 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 .s4 { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; }
 .a, a { color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 #l2 {padding-left: 0pt;counter-reset: c2 2; }
 #l2> li>*:first-child:before {counter-increment: c2; content: counter(c2, lower-latin)"). "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: c2 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 1; }
 #l3> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l4 {padding-left: 0pt;counter-reset: e1 1; }
 #l4> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l4> li:first-child>*:first-child:before {counter-increment: e1 0;  }
 #l5 {padding-left: 0pt;counter-reset: e2 1; }
 #l5> li>*:first-child:before {counter-increment: e2; content: counter(e2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l5> li:first-child>*:first-child:before {counter-increment: e2 0;  }
 li {display: block; }
 #l6 {padding-left: 0pt;counter-reset: f1 2; }
 #l6> li>*:first-child:before {counter-increment: f1; content: counter(f1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l6> li:first-child>*:first-child:before {counter-increment: f1 0;  }
 #l7 {padding-left: 0pt;counter-reset: f2 1; }
 #l7> li>*:first-child:before {counter-increment: f2; content: counter(f2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l7> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 #l8 {padding-left: 0pt;counter-reset: f2 1; }
 #l8> li>*:first-child:before {counter-increment: f2; content: counter(f2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l8> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 #l9 {padding-left: 0pt;counter-reset: f2 1; }
 #l9> li>*:first-child:before {counter-increment: f2; content: counter(f2, lower-latin)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l9> li:first-child>*:first-child:before {counter-increment: f2 0;  }
 li {display: block; }
 #l10 {padding-left: 0pt;counter-reset: g1 1; }
 #l10> li>*:first-child:before {counter-increment: g1; content: counter(g1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l10> li:first-child>*:first-child:before {counter-increment: g1 0;  }
 li {display: block; }
 #l11 {padding-left: 0pt;counter-reset: h1 2; }
 #l11> li>*:first-child:before {counter-increment: h1; content: counter(h1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l11> li:first-child>*:first-child:before {counter-increment: h1 0;  }
 #l12 {padding-left: 0pt;counter-reset: h2 1; }
 #l12> li>*:first-child:before {counter-increment: h2; content: counter(h2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l12> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 #l13 {padding-left: 0pt;counter-reset: h2 1; }
 #l13> li>*:first-child:before {counter-increment: h2; content: counter(h2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l13> li:first-child>*:first-child:before {counter-increment: h2 0;  }
 li {display: block; }
 #l14 {padding-left: 0pt;counter-reset: i1 1; }
 #l14> li>*:first-child:before {counter-increment: i1; content: counter(i1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l14> li:first-child>*:first-child:before {counter-increment: i1 0;  }
 li {display: block; }
 #l15 {padding-left: 0pt;counter-reset: j1 2; }
 #l15> li>*:first-child:before {counter-increment: j1; content: counter(j1, decimal)" "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l15> li:first-child>*:first-child:before {counter-increment: j1 0;  }
 #l16 {padding-left: 0pt;counter-reset: j2 1; }
 #l16> li>*:first-child:before {counter-increment: j2; content: counter(j2, lower-latin)") "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l16> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 #l17 {padding-left: 0pt;counter-reset: j2 1; }
 #l17> li>*:first-child:before {counter-increment: j2; content: counter(j2, lower-latin)") "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l17> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 #l18 {padding-left: 0pt;counter-reset: j2 1; }
 #l18> li>*:first-child:before {counter-increment: j2; content: counter(j2, lower-latin)") "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l18> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 #l19 {padding-left: 0pt;counter-reset: j3 1; }
 #l19> li>*:first-child:before {counter-increment: j3; content: counter(j3, lower-roman)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l19> li:first-child>*:first-child:before {counter-increment: j3 0;  }
 #l20 {padding-left: 0pt;counter-reset: j3 1; }
 #l20> li>*:first-child:before {counter-increment: j3; content: counter(j3, lower-roman)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l20> li:first-child>*:first-child:before {counter-increment: j3 0;  }
 #l21 {padding-left: 0pt;counter-reset: j2 1; }
 #l21> li>*:first-child:before {counter-increment: j2; content: counter(j2, lower-latin)") "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l21> li:first-child>*:first-child:before {counter-increment: j2 0;  }
 li {display: block; }
 #l22 {padding-left: 0pt;counter-reset: k1 1; }
 #l22> li>*:first-child:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l22> li:first-child>*:first-child:before {counter-increment: k1 0;  }
 li {display: block; }
 #l23 {padding-left: 0pt;counter-reset: l1 1; }
 #l23> li>*:first-child:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-style: normal; font-weight: normal; text-decoration: none; }
 #l23> li:first-child>*:first-child:before {counter-increment: l1 0;  }
 #l24 {padding-left: 0pt;counter-reset: l2 1; }
 #l24> li>*:first-child:before {counter-increment: l2; content: counter(l2, lower-latin)") "; color: black; font-family:"Lucida Sans Unicode", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; }
 #l24> li:first-child>*:first-child:before {counter-increment: l2 0;  }
</style><link rel="sitemap" type="application/xml" title="Sitemap" href="/sitemap.xml"></head><body><div style="display:flex;justify-content:flex-end;"><a href="#" target="_blank" download="" id="pdf-download-link"><button type="button" style="cursor:pointer;-webkit-appearance:button;color:#fff;background-color:#007bff;border-color:#007bff;display:inline-block;font-weight:400;text-align:center;white-space:nowrap;vertical-align:middle;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;border:1px solid transparent;padding:0.375rem 0.75rem;font-size:1rem;line-height:1.5;border-radius:0.25rem;transition:color .15s ease-in-out,background-color .15s ease-in-out,border-color .15s ease-in-out,box-shadow .15s ease-in-out;text-transform:none;overflow:visible;margin:0;font-family:inherit;" download>Download</button></a></div><script>const a=(window.location.pathname).split("/");const filename="" + a[a.length-1] + ".pdf";document.getElementById("pdf-download-link").href=filename;</script><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -56pt;line-height: 113%;text-align: left;">ADVANCED SPECTRAL ANALYSIS (MPC 201T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">This subject deals with various hyphenated analytical instrumental techniques for identification, characterization and quantification of drugs. Instruments dealt are LC-MS, GC-MS, ATR-IR, DSC etc.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">At completion of this course it is expected that students will be able to understand-</p><p class="s2" style="padding-left: 41pt;text-indent: -18pt;line-height: 89%;text-align: left;">  <span class="p">Interpretation of the NMR, Mass and IR spectra of various organic compounds</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Theoretical and practical skills of the hyphenated instruments</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Identification of organic compounds</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">THEORY                                60Hrs</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1.  <span class="s2">UV and IR spectroscopy:</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Wood ward – Fieser rule for 1,3- butadienes, cyclic dienes and α, β-carbonyl compounds and interpretation compounds of enones. ATR-IR, IR Interpretation of organic compounds.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l1"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 12pt;text-align: left;">NMR spectroscopy:</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">1-D and 2-D NMR, NOESY and COSY, HECTOR, INADEQUATE</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">techniques, Interpretation of organic compounds.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;text-align: left;">Mass Spectroscopy</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Mass fragmentation and its rules, Fragmentation of important functional groups like alcohols, amines, carbonyl groups and alkanes, Meta stable ions, Mc Lafferty rearrangement, Ring rule, Isotopic peaks, Interpretation of organic compounds.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Chromatography:</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Principle, Instrumentation and Applications of the following :</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">a) GC-MS b) GC-AAS c) LC-MS d) LC-FTIR e) LC-NMR f) CE-</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">MS g) High Performance Thin Layer chromatography h) Super critical fluid chromatography i) Ion Chromatography j) I-EC (Ion- Exclusion Chromatography) k) Flash chromatography</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li><li data-list-text="5"><p class="s2" style="padding-top: 2pt;padding-left: 28pt;text-indent: -22pt;line-height: 13pt;text-align: left;">a). Thermal methods of analysis</p><p style="padding-left: 41pt;text-indent: -3pt;line-height: 86%;text-align: left;">Introduction, principle, instrumentation and application of DSC, DTA and TGA.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l2"><li data-list-text="b)."><p class="s2" style="padding-left: 41pt;text-indent: -13pt;text-align: left;">Raman Spectroscopy</p><p style="padding-top: 4pt;padding-left: 42pt;text-indent: 0pt;text-align: left;">Introduction, Principle, Instrumentation and Applications.</p></li><li data-list-text="c)."><p class="s2" style="padding-top: 6pt;padding-left: 40pt;text-indent: -12pt;text-align: left;">Radio immuno assay</p></li></ol></li></ol><p style="padding-top: 3pt;padding-left: 41pt;text-indent: -1pt;line-height: 86%;text-align: left;">Biological standardization , bioassay, ELISA, Radioimmuno assay of digitalis and insulin.</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l3"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Spectrometric Identification of Organic compounds - Robert M Silverstein, Sixth edition, John Wiley &amp; Sons, 2004.</p></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Principles of Instrumental Analysis - Doglas A Skoog, F. James Holler, Timothy A. Nieman, 5<span class="s3">th </span>edition, Eastern press, Bangalore, 1998.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 9pt;text-align: left;">Instrumental methods of analysis – Willards, 7<span class="s3">th </span>edition, CBS publishers.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Organic Spectroscopy - William Kemp, 3<span class="s3">rd </span>edition, ELBS, 1991.</p></li><li data-list-text="5."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quantitative analysis of Pharmaceutical formulations by HPTLC - P D Sethi, CBS Publishers, New Delhi.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Quantitative Analysis of Drugs in Pharmaceutical formulation - P D Sethi, 3<span class="s3">rd </span>Edition, CBS Publishers, New Delhi, 1997.</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Pharmaceutical Analysis- Modern methods – Part B - J W Munson, Volume 11, Marcel Dekker Series</p></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 71pt;text-indent: 0pt;line-height: 113%;text-align: center;">ADVANCED ORGANIC CHEMISTRY - II (MPC 202T)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 87%;text-align: justify;">The subject is designed to provide in-depth knowledge about advances in organic chemistry, different techniques of organic synthesis and their applications to process chemistry as well as drug discovery.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 2pt;padding-left: 3pt;text-indent: 0pt;line-height: 13pt;text-align: center;">Upon completion of course, the student shall able to understand</p><p class="s2" style="padding-left: 3pt;text-indent: 0pt;line-height: 12pt;text-align: center;">  <span class="p">The principles and applications of Green chemistry</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The concept of peptide chemistry.</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">The various catalysts used in organic reactions</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">The concept of stereochemistry and asymmetric synthesis.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 3pt;text-indent: 0pt;text-align: center;">THEORY                                60 Hrs</p><ol id="l4"><li data-list-text="1."><p class="s2" style="padding-top: 1pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Green Chemistry:</p><ol id="l5"><li data-list-text="a."><p style="padding-left: 42pt;text-indent: -15pt;line-height: 12pt;text-align: justify;">Introduction, principles of green chemistry</p></li><li data-list-text="b."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 86%;text-align: justify;">Microwave assisted reactions: Merit and demerits of its use, increased reaction rates, mechanism, superheating effects of microwave, effects of solvents in microwave assisted synthesis, microwave technology in process optimization, its applications in various organic reactions and heterocycles synthesis</p></li><li data-list-text="c."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 85%;text-align: justify;">Ultrasound assisted reactions: Types of sonochemical reactions, homogenous, heterogeneous liquid-liquid and liquid-solid reactions, synthetic applications</p></li><li data-list-text="d."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 86%;text-align: justify;">Continuous flow reactors: Working principle, advantages and synthetic applications.</p></li></ol></li></ol><ol id="l6"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 11pt;text-align: left;">Chemistry of peptides</p><ol id="l7"><li data-list-text="a."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 12pt;text-align: justify;">Coupling reactions in peptide synthesis</p></li><li data-list-text="b."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 86%;text-align: justify;">Principles of solid phase peptide synthesis, t-BOC and FMOC protocols, various solid supports and linkers: Activation procedures, peptide bond formation, deprotection and cleavage from resin, low and high HF cleavage protocols, formation of free peptides and peptide amides, purification and case studies, site-specific chemical modifications of peptides</p></li><li data-list-text="c."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 85%;text-align: justify;">Segment and sequential strategies for solution phase peptide synthesis with any two case studies</p></li><li data-list-text="d."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 12pt;text-align: justify;">Side reactions in peptide synthesis: Deletion peptides, side</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-top: 2pt;padding-left: 41pt;text-indent: 0pt;line-height: 86%;text-align: left;">reactions initiated by proton abstraction, protonation, over- activation and side reactions of individual amino acids.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="3"><p class="s2" style="padding-top: 3pt;padding-left: 28pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Photochemical Reactions</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Basic principles of photochemical reactions. Photo-oxidation, photo-addition and photo-fragmentation.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;text-align: justify;">Pericyclic reactions</p><p style="padding-top: 3pt;padding-left: 27pt;text-indent: 0pt;line-height: 85%;text-align: justify;">Mechanism, Types of pericyclic reactions such as cyclo addition, electrocyclic reaction and sigmatrophic rearrangement reactions with examples</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Catalysis:</p><ol id="l8"><li data-list-text="a."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 85%;text-align: justify;">Types of catalysis, heterogeneous and homogenous catalysis, advantages and disadvantages</p></li><li data-list-text="b."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 86%;text-align: justify;">Heterogeneous catalysis – preparation, characterization, kinetics, supported catalysts, catalyst deactivation and regeneration, some examples of heterogeneous catalysis used in synthesis of drugs.</p></li><li data-list-text="c."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 87%;text-align: justify;">Homogenous catalysis, hydrogenation, hydroformylation, hydrocyanation, Wilkinson catalysts, chiral ligands and chiral induction, Ziegler‐Natta catalysts, some examples of homogenous catalysis used in synthesis of drugs</p></li><li data-list-text="d."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 11pt;text-align: justify;">Transition-metal and Organo-catalysis in organic synthesis:</p><p style="padding-left: 41pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">Metal-catalyzed reactions</p></li><li data-list-text="e."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 87%;text-align: justify;">Biocatalysis: Use of enzymes in organic synthesis, immobilized enzymes/cells in organic reaction.</p></li><li data-list-text="f."><p style="padding-left: 41pt;text-indent: -13pt;line-height: 12pt;text-align: justify;">Phase transfer catalysis ‐ theory and applications</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Stereochemistry &amp; Asymmetric Synthesis</p><ol id="l9"><li data-list-text="a."><p style="padding-left: 41pt;text-indent: -12pt;line-height: 86%;text-align: justify;">Basic concepts in stereochemistry – optical activity, specific rotation, racemates and resolution of racemates, the Cahn, Ingold, Prelog (CIP) sequence rule, meso compounds, pseudo asymmetric centres, axes of symmetry, Fischers D and L notation, cis-trans isomerism, E and Z notation.</p></li><li data-list-text="b."><p style="padding-left: 41pt;text-indent: -12pt;line-height: 85%;text-align: justify;">Methods of asymmetric synthesis using chiral pool, chiral auxiliaries and catalytic asymmetric synthesis, enantiopure separation and Stereo selective synthesis with examples.</p></li></ol></li></ol><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l10"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -13pt;line-height: 87%;text-align: left;">“Advanced Organic chemistry, Reaction, mechanisms and structure”, J March, John Wiley and sons, New York.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 86%;text-align: left;">“Mechanism and structure in organic chemistry”, ES Gould, Hold Rinchart and Winston,NewYork.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 10pt;text-align: left;">“Organic Chemistry” Clayden, Greeves, Warren and Woihers., Oxford</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 12pt;text-align: left;">University Press 2001.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 12pt;text-align: left;">“Organic Chemistry” Vol I and II. I.L. Finar. ELBS, Sixth ed., 1995.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Carey, Organic chemistry, 5th edition (Viva Books Pvt. Ltd.)</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Organic synthesis-the disconnection approach, S. Warren, Wily India</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Principles of organic synthesis, ROCNorman and JMCoxan, Nelson thorns</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 86%;text-align: left;">Organic synthesis- Special techniques VK Ahluwalia and R Aggarwal, Narosa Publishers.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -13pt;line-height: 83%;text-align: left;">Organic reaction mechanisms IV edtn, VK Ahluwalia and RK Parashar, Narosa Publishers.</p></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 138pt;text-indent: -55pt;line-height: 113%;text-align: left;">COMPUTER AIDED DRUG DESIGN (MPC 203T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">The subject is designed to impart knowledge on the current state of the art techniques involved in computer assisted drug design.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 85%;text-align: left;">At completion of this course it is expected that students will be able to understand</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Role of CADD in drug discovery</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">Different CADD techniques and their applications</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">Various strategies to design and develop new drug like molecules.</span></p><p class="s2" style="padding-top: 2pt;padding-left: 41pt;text-indent: -18pt;line-height: 86%;text-align: left;">  <span class="p">Working with molecular modeling softwares to design new drug molecules</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 11pt;text-align: left;">  <span class="p">The </span>in silico <span class="p">virtual screening protocols</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Theory                                  60 Hrs</p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">1. <span class="s2">Introduction to Computer Aided Drug Design (CADD)</span></p><p style="padding-top: 8pt;padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: justify;">History, different techniques and applications.</p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 9pt;text-align: justify;">Quantitative Structure Activity Relationships: Basics</p><p style="padding-top: 4pt;padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">History and development of QSAR: Physicochemical parameters and methods to calculate physicochemical parameters: Hammett equation and electronic parameters (sigma), lipophilicity effects and parameters (log P, pi-substituent constant), steric effects (Taft steric and MR parameters) Experimental and theoretical approaches for the determination of these physicochemical parameters.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l11"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 86%;text-align: left;">Quantitative Structure Activity Relationships: Applications <span class="p">Hansch analysis, Free Wilson analysis and relationship between them, Advantages and disadvantages; Deriving 2D-QSAR equations.</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 10pt;text-align: left;">3D-QSAR approaches and contour map analysis.</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 82%;text-align: left;">Statistical methods used in QSAR analysis and importance of statistical parameters.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Molecular Modeling and Docking</p><ol id="l12"><li data-list-text="a)"><p style="padding-left: 48pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Molecular and Quantum Mechanics in drug design.</p></li><li data-list-text="b)"><p style="padding-left: 48pt;text-indent: -14pt;line-height: 13pt;text-align: left;">Energy Minimization Methods: comparison between global</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="padding-left: 48pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">minimum conformation and bioactive conformation</p></li><li data-list-text="c)"><p style="padding-left: 48pt;text-indent: -14pt;line-height: 85%;text-align: justify;">Molecular docking and drug receptor interactions: Rigid docking, flexible docking and extra-precision docking. Agents acting on enzymes such as DHFR, HMG-CoA reductase and HIV protease, choline esterase ( AchE &amp; BchE)</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="4"><p class="s2" style="padding-top: 3pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Molecular Properties and Drug Design</p><ol id="l13"><li data-list-text="a)"><p style="padding-left: 48pt;text-indent: -14pt;line-height: 86%;text-align: justify;">Prediction and analysis of ADMET properties of new molecules and its importance in drug design.</p></li><li data-list-text="b)"><p class="s2" style="padding-left: 48pt;text-indent: -14pt;line-height: 87%;text-align: justify;">De novo <span class="p">drug design: Receptor/enzyme-interaction and its analysis, Receptor/enzyme cavity size prediction, predicting the functional components of cavities, Fragment based drug design.</span></p></li><li data-list-text="c)"><p style="padding-left: 48pt;text-indent: -14pt;line-height: 84%;text-align: justify;">Homology modeling and generation of 3D-structure of protein.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Pharmacophore Mapping and Virtual Screening</p></li></ol><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Concept of pharmacophore, pharmacophore mapping, identification of Pharmacophore features and Pharmacophore modeling; Conformational search used in pharmacophore mapping.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 27pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">In Silico <span class="p">Drug Design and Virtual Screening Techniques</span></p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 81%;text-align: justify;">Similarity based methods and Pharmacophore based screening, structure based <span class="s2">In-silico </span>virtual screening protocols.</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-top: 4pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l14"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Computational and structural approaches to drug discovery, Robert M Stroud and Janet. F Moore, RCS Publishers.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Introduction to Quantitative Drug Design by Y.C. Martin, CRC Press, Taylor &amp; Francis group..</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Drug Design by Ariens Volume 1 to 10, Academic Press, 1975, Elsevier Publishers.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Principles of Drug Design by Smith and Williams, CRC Press, Taylor &amp; Francis.</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">The Organic Chemistry of the Drug Design and Drug action by Richard B. Silverman, Elsevier Publishers.</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Medicinal Chemistry by Burger, Wiley Publishing Co.</p></li><li data-list-text="7."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -14pt;line-height: 71%;text-align: left;">An Introduction to Medicinal Chemistry –Graham L. Patrick, Oxford University Press.</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Wilson and Gisvold’s Text book of Organic Medicinal and Pharmaceutical Chemistry, Ippincott Williams &amp; Wilkins.</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">Comprehensive Medicinal Chemistry – Corwin and Hansch, Pergamon Publishers.</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 84%;text-align: left;">Computational and structural approaches to drug design edited by Robert M Stroud and Janet. F Moore</p></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 141pt;text-indent: -76pt;line-height: 113%;text-align: left;">PHARMACEUTICAL PROCESS CHEMISTRY (MPC 204T)</p><p class="s2" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Scope</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: justify;">Process chemistry is often described as scale up reactions, taking them from small quantities created in the research lab to the larger quantities that are needed for further testing and then to even larger quantities required for commercial production. The goal of a process chemist is to develop synthetic routes that are safe, cost-effective, environmentally friendly, and efficient. The subject is designed to impart knowledge on the development and optimization of a synthetic route/s and the pilot plant procedure for the manufacture of Active Pharmaceutical Ingredients (APIs) and new chemical entities (NCEs) for the drug development phase.</p><p class="s2" style="padding-top: 7pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Objectives</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;line-height: 86%;text-align: left;">At completion of this course it is expected that students will be able to understand</p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 12pt;text-align: left;">  <span class="p">The strategies of scale up process of apis and intermediates</span></p><p class="s2" style="padding-left: 23pt;text-indent: 0pt;line-height: 13pt;text-align: left;">  <span class="p">The various unit operations and various reactions in process chemistry</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">THEORY                                 60 Hrs</p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">1. <span class="s2">Process chemistry</span></p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Introduction, Synthetic strategy</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 86%;text-align: left;">Stages of scale up process: Bench, pilot and large scale process. In-process control and validation of large scale process.</p><p style="padding-left: 27pt;text-indent: 0pt;line-height: 11pt;text-align: left;">Case studies of some scale up process of APIs.</p><p style="padding-top: 1pt;padding-left: 27pt;text-indent: 0pt;line-height: 82%;text-align: left;">Impurities in API, types and their sources including genotoxic impurities</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l15"><li data-list-text="2"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 12pt;text-align: left;">Unit operations</p><ol id="l16"><li data-list-text="a)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 86%;text-align: left;">Extraction: <span class="p">Liquid equilibria, extraction with reflux, extraction with agitation, counter current extraction.</span></p></li><li data-list-text="b)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 88%;text-align: left;">Filtration<span class="p">: Theory of filtration, pressure and vacuum filtration, centrifugal filtration,</span></p></li><li data-list-text="c)"><p class="s2" style="padding-left: 63pt;text-indent: -17pt;line-height: 11pt;text-align: left;">Distillation<span class="p">: azeotropic and steam distillation</span></p></li><li data-list-text="d)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 86%;text-align: justify;">Evaporation<span class="p">: Types of evaporators, factors affecting evaporation.</span></p></li><li data-list-text="e)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 86%;text-align: justify;">Crystallization<span class="p">: Crystallization from aqueous, non- aqueous solutions factors affecting crystallization, nucleation. Principle and general methods of Preparation of polymorphs, hydrates, solvates and amorphous APIs.</span></p><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p></li></ol></li><li data-list-text="3"><p class="s2" style="padding-top: 2pt;padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Unit Processes - I</p><ol id="l17"><li data-list-text="a)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 83%;text-align: left;">Nitration: <span class="p">Nitrating agents, Aromatic nitration, kinetics and mechanism of aromatic nitration, process equipment for technical nitration, mixed acid for nitration,</span></p></li><li data-list-text="b)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 88%;text-align: justify;">Halogenation: <span class="p">Kinetics of halogenations, types of halogenations, catalytic halogenations. Case study on industrial halogenation process.</span></p></li><li data-list-text="c)"><p style="padding-left: 63pt;text-indent: -18pt;line-height: 86%;text-align: justify;"><span class="s2">Oxidation</span>: Introduction, types of oxidative reactions, Liquid phase oxidation with oxidizing agents. Nonmetallic Oxidizing agents such as H<span class="s4">2</span>O<span class="s4">2</span>, sodium hypochlorite, Oxygen gas, ozonolysis.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li data-list-text="4"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Unit Processes - II</p><ol id="l18"><li data-list-text="a)"><p class="s2" style="padding-left: 63pt;text-indent: -18pt;line-height: 86%;text-align: left;">Reduction: <span class="p">Catalytic hydrogenation, Heterogeneous and homogeneous catalyst; Hydrogen transfer reactions, Metal hydrides. Case study on industrial reduction process.</span></p></li><li data-list-text="b)"><p class="s2" style="padding-left: 63pt;text-indent: -17pt;line-height: 10pt;text-align: left;">Fermentation<span class="p">: Aerobic and anaerobic fermentation.</span></p><p style="padding-left: 63pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Production of</p><ol id="l19"><li data-list-text="i."><p style="padding-left: 76pt;text-indent: -11pt;line-height: 12pt;text-align: left;">Antibiotics; Penicillin and Streptomycin,</p></li><li data-list-text="ii."><p style="padding-left: 76pt;text-indent: -13pt;line-height: 12pt;text-align: left;">Vitamins: B2 and B12</p></li><li data-list-text="iii."><p style="padding-left: 76pt;text-indent: -15pt;line-height: 12pt;text-align: left;">Statins: Lovastatin, Simvastatin</p></li></ol></li><li data-list-text="c)"><p class="s2" style="padding-left: 60pt;text-indent: -12pt;line-height: 12pt;text-align: left;">Reaction progress kinetic analysis</p><ol id="l20"><li data-list-text="i."><p style="padding-left: 76pt;text-indent: -11pt;line-height: 12pt;text-align: justify;">Streamlining reaction steps, route selection,</p></li><li data-list-text="ii."><p style="padding-left: 76pt;text-indent: -13pt;line-height: 85%;text-align: justify;">Characteristics of expedient routes, characteristics of cost-effective routes, reagent selection, families of reagents useful for scale-up.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li></ol></li><li data-list-text="5"><p class="s2" style="padding-left: 27pt;text-indent: -22pt;line-height: 13pt;text-align: left;">Industrial Safety</p><ol id="l21"><li data-list-text="a)"><p style="padding-left: 64pt;text-indent: -17pt;line-height: 86%;text-align: justify;">MSDS (Material Safety Data Sheet), hazard labels of chemicals and Personal Protection Equipment (PPE)</p></li><li data-list-text="b)"><p style="padding-left: 63pt;text-indent: -17pt;line-height: 11pt;text-align: justify;">Fire hazards, types of fire &amp; fire extinguishers</p></li><li data-list-text="c)"><p style="padding-left: 63pt;text-indent: -17pt;line-height: 85%;text-align: justify;">Occupational Health &amp; Safety Assessment Series 1800 (OHSAS-1800)   and   ISO-14001(Environmental Management System), Effluents and its management</p></li></ol></li></ol><p style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">12</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Hrs</p><p class="s2" style="padding-top: 3pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">REFERENCES</p><ol id="l22"><li data-list-text="1."><p style="padding-top: 3pt;padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Process Chemistry in the Pharmaceutical Industry: Challenges in an Ever- Changing Climate-An Overview; K. Gadamasetti, CRC Press.</p></li><li data-list-text="2."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">Pharmaceutical Manufacturing Encyclopedia, 3<span class="s3">rd </span>edition, Volume 2.</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Medicinal Chemistry by Burger, 6<span class="s3">th </span>edition, Volume 1-8.</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 86%;text-align: left;">W.L. McCabe, J.C Smith, Peter Harriott. Unit operations of chemical engineering, 7th edition, McGraw Hill</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Polymorphism in Pharmaceutical Solids .Dekker Series Volume 95 Ed: H G Brittain (1999)</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">Regina M. Murphy: Introduction to Chemical Processes: Principles, Analysis, Synthesis</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 87%;text-align: left;">Peter J. Harrington: Pharmaceutical Process Chemistry for Synthesis: Rethinking the Routes to Scale-Up</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 10pt;text-align: left;">P.H.Groggins: Unit processes in organic synthesis (MGH)</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">F.A.Henglein: Chemical Technology (Pergamon)</p></li><li data-list-text="10."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">M.Gopal: Dryden’s Outlines of Chemical Technology, WEP East-West Press</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">Clausen,Mattson: Principle of Industrial Chemistry, Wiley Publishing Co.,</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Lowenheim &amp; M.K. Moran: Industrial Chemicals</p></li><li data-list-text="13."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -14pt;line-height: 85%;text-align: left;">S.D. Shukla &amp; G.N. Pandey: A text book of Chemical Technology Vol. II, Vikas Publishing House</p></li><li data-list-text="14."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 11pt;text-align: left;">J.K. Stille: Industrial Organic Chemistry (PH)</p></li><li data-list-text="15."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">Shreve: Chemical Process, Mc Grawhill.</p></li><li data-list-text="16."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">B.K.Sharma: Industrial Chemistry, Goel Publishing House</p></li><li data-list-text="17."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 12pt;text-align: left;">ICH Guidelines</p></li><li data-list-text="18."><p style="padding-left: 26pt;text-indent: -14pt;line-height: 13pt;text-align: left;"><a href="http://www.fda.gov/" class="a" target="_blank">United States Food and Drug Administration official website </a><a href="http://www.fda.gov/" target="_blank">www.fda.gov</a></p></li></ol><p class="s1" style="padding-top: 3pt;padding-left: 141pt;text-indent: -92pt;line-height: 113%;text-align: left;">PHARMACEUTICAL CHEMISTRY PRACTICALS – II (MPC 205P)</p><ol id="l23"><li data-list-text="1."><p style="padding-top: 4pt;padding-left: 26pt;text-indent: -18pt;line-height: 85%;text-align: left;">Synthesis of organic compounds by adapting different approaches involving (3 experiments)</p><ol id="l24"><li data-list-text="a)"><p style="padding-left: 41pt;text-indent: -11pt;line-height: 9pt;text-align: left;">Oxidation</p></li><li data-list-text="b)"><p style="padding-left: 41pt;text-indent: -11pt;line-height: 12pt;text-align: left;">Reduction/hydrogenation</p></li><li data-list-text="c)"><p style="padding-left: 41pt;text-indent: -11pt;line-height: 13pt;text-align: left;">Nitration</p></li></ol></li><li data-list-text="2."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -18pt;line-height: 85%;text-align: left;">Comparative study of synthesis of APIs/intermediates by different synthetic routes (2 experiments)</p></li><li data-list-text="3."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 11pt;text-align: left;">Assignments on regulatory requirements in API (2 experiments)</p></li><li data-list-text="4."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Comparison of absorption spectra by UV and Wood ward – Fieser rule</p></li><li data-list-text="5."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by FT-IR</p></li><li data-list-text="6."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by NMR</p></li><li data-list-text="7."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Interpretation of organic compounds by MS</p></li><li data-list-text="8."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 12pt;text-align: left;">Determination of purity by DSC in pharmaceuticals</p></li><li data-list-text="9."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 85%;text-align: left;">Identification of organic compounds using FT-IR, NMR, CNMR and Mass spectra</p></li><li data-list-text="10."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 11pt;text-align: left;">To carry out the preparation of following organic compounds</p></li><li data-list-text="11."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 86%;text-align: left;">Preparation of 4-chlorobenzhydrylpiperazine. (an intermediate for cetirizine HCl).</p></li><li data-list-text="12."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 10pt;text-align: left;">Preparation of 4-iodotolene from p-toluidine.</p></li><li data-list-text="13."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">NaBH<span class="s4">4 </span>reduction of vanillin to vanillyl alcohol</p></li><li data-list-text="14."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Preparation of umbelliferone by Pechhman reaction</p></li><li data-list-text="15."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Preparation of triphenyl imidazole</p></li><li data-list-text="16."><p style="padding-top: 1pt;padding-left: 26pt;text-indent: -18pt;line-height: 86%;text-align: left;">To perform the Microwave irradiated reactions of synthetic importance (Any two)</p></li><li data-list-text="17."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 86%;text-align: left;">Determination of log P, MR, hydrogen bond donors and acceptors of selected drugs using softwares</p></li><li data-list-text="18."><p style="padding-left: 26pt;text-indent: -18pt;line-height: 86%;text-align: left;">Calculation of ADMET properties of drug molecules and its analysis using softwares</p><p style="padding-left: 26pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Pharmacophore modeling</p></li><li data-list-text="19."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">2D-QSAR based experiments</p></li><li data-list-text="20."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">3D-QSAR based experiments</p></li><li data-list-text="21."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 12pt;text-align: left;">Docking study based experiment</p></li><li data-list-text="22."><p style="padding-left: 26pt;text-indent: -17pt;line-height: 13pt;text-align: left;">Virtual screening based experiment</p></li></ol></body></html>
